These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 24604039)

  • 1. Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.
    Umamaheswaran G; Kumar DK; Adithan C
    Indian J Med Res; 2014 Jan; 139(1):27-65. PubMed ID: 24604039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.
    Bosó V; Herrero MJ; Buso E; Galán J; Almenar L; Sánchez-Lázaro I; Sánchez-Plumed J; Bea S; Prieto M; García M; Pastor A; Sole A; Poveda JL; Aliño SF
    Ther Drug Monit; 2014 Apr; 36(2):159-68. PubMed ID: 24232128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
    Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
    Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.
    Umamaheswaran G; Krishna Kumar D; Kayathiri D; Rajan S; Shewade DG; Dkhar SA; Manjunath S; Ushakiran P; Reneega G; Ritushree K; Adithan C
    Mol Biol Rep; 2012 May; 39(5):6343-51. PubMed ID: 22318545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore.
    Chowbay B; Zhou S; Lee EJ
    Drug Metab Rev; 2005; 37(2):327-78. PubMed ID: 15931768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.
    Ni W; Ji J; Dai Z; Papp A; Johnson AJ; Ahn S; Farley KL; Lin TS; Dalton JT; Li X; Jarjoura D; Byrd JC; Sadee W; Grever MR; Phelps MA
    PLoS One; 2010 Nov; 5(11):e13792. PubMed ID: 21072184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.
    Jittikoon J; Mahasirimongkol S; Charoenyingwattana A; Chaikledkaew U; Tragulpiankit P; Mangmool S; Inunchot W; Somboonyosdes C; Wichukchinda N; Sawanpanyalert P; He Y; McLeod HL; Chantratita W
    J Hum Genet; 2016 Feb; 61(2):119-27. PubMed ID: 26423926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
    Ozawa S
    Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.
    Cerda A; Hirata MH; Hirata RD
    Drug Metabol Drug Interact; 2014; 29(3):153-77. PubMed ID: 24744305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of SLCO1B1: haplotypes, htSNPs and hepatic expression in three distinct Asian populations.
    Jada SR; Xiaochen S; Yan LY; Xiaoqiang X; Lal S; Zhou SF; Ooi LL; Chowbay B
    Eur J Clin Pharmacol; 2007 Jun; 63(6):555-63. PubMed ID: 17415554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of membrane transporters: a review of current approaches.
    Sissung TM; Goey AK; Ley AM; Strope JD; Figg WD
    Methods Mol Biol; 2014; 1175():91-120. PubMed ID: 25150868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADME pharmacogenetics: future outlook for Russia.
    Mirzaev KB; Fedorinov DS; Ivashchenko DV; Sychev DA
    Pharmacogenomics; 2019 Jul; 20(11):847-865. PubMed ID: 31368406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.
    Giri AK; Khan NM; Grover S; Kaur I; Basu A; Tandon N; Scaria V; ; ; Kukreti R; Brahmachari SK; Bharadwaj D
    Pharmacogenomics; 2014 Jul; 15(10):1337-54. PubMed ID: 25155935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment.
    Yi S; An H; Lee H; Lee S; Ieiri I; Lee Y; Cho JY; Hirota T; Fukae M; Yoshida K; Nagatsuka S; Kimura M; Irie S; Sugiyama Y; Shin DW; Lim KS; Chung JY; Yu KS; Jang IJ
    Pharmacogenet Genomics; 2014 Oct; 24(10):477-85. PubMed ID: 25029633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition to adverse drug reactions in the intensive care unit.
    Empey PE
    Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.
    Wang T; Zhou Y; Cao G
    Eur J Clin Pharmacol; 2021 Aug; 77(8):1095-1111. PubMed ID: 33515076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of antimalarial drugs: effect on metabolism and transport.
    Kerb R; Fux R; Mörike K; Kremsner PG; Gil JP; Gleiter CH; Schwab M
    Lancet Infect Dis; 2009 Dec; 9(12):760-74. PubMed ID: 19926036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.